Guretolimod
- Generic Name
- Guretolimod
A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03416335
- Locations
- 🇺🇸
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸M.D. Anderson Cancer Center, The University of Texas, Houston, Texas, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath